Novel Autologou CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma
Clinical trial NCT03258047 · UNKNOWN
Trial details
- NCT number
- NCT03258047
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-15
- Primary completion
- 2019-01-13
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.